Research tools and platforms in the Bio-Link portfolio that are available for licensing and partnership include the following:

Novel cytoskeleton biology and drug screening tools

A leading research laboratory at the Children’s Cancer Institute developed a set of three gene-edited lung cancer cell lines expressing GFP-tagged βIII-tubulin and its strategic structural variations. These “off the shelf” tools have broad applications in basic tubulin and cytoskeletal biology research, in cell-based drug screening assays and in drug development for monitoring the efficacy of novel modulators. We are seeking a research reagents company to enter into a supply and distribution partnership for the commercialisation of these well characterised, superior research tools. Summary (PDF)